The Current Landscape of In Silico Drug Discovery

Thursday, 29 September 2016 at 09:45

Add to Calendar ▼2016-09-29 09:45:002016-09-29 10:45:00Europe/LondonThe Current Landscape of In Silico Drug DiscoveryIn Silico Drug Discovery and Predictive Toxicology 2016 in San Diego, California, USASan Diego, California, USASELECTBIOenquiries@selectbiosciences.com

Shahar Keinan, Chief Scientific Officer, Cloud Pharmaceuticals

Shahar Keinan

Shahar Keinan is the Chief Scientific Officer and co-founder of Cloud Pharmaceuticals. She has over 20 years of extensive experience in the field of computational and theoretical chemistry. Shahar has received a Ph.D. in theoretical chemistry from The Hebrew University of Jerusalem and has numerous papers and presentations in the fields of in-silico drug design and discovery, as well as molecular materials design and computational methods development.